Hanson & Doremus Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $34K | Sell |
|
|||||
|
2021
Q4 | $37K | Hold |
|
|||||
|
2021
Q3 | $45K | Sell |
|
|||||
|
2021
Q2 | $166K | Buy |
|
|||||
|
2021
Q1 | $171K | Sell |
|
|||||
|
2020
Q4 | $146K | Sell |
|
|||||
|
2020
Q3 | $166K | Sell |
|
|||||
|
2020
Q2 | $231K | Sell |
|
|||||
|
2020
Q1 | $193K | Sell |
|
|||||
|
2019
Q4 | $213K | Sell |
|
|||||
|
2019
Q3 | $209K | Sell |
|
|||||
|
2019
Q2 | $386K | Buy |
|
|||||
|
2019
Q1 | $649K | Sell |
|
|||||
|
2018
Q4 | $680K | Sell |
|
|||||
|
2018
Q3 | $1.05M | Buy |
|
|||||
|
2018
Q2 | $1.18M | Sell |
|
|||||
|
2018
Q1 | $828K | Buy |
|
|||||
|
2017
Q4 | $854K | Sell |
|
|||||
|
2017
Q3 | $1.06M | Buy |
|
|||||
|
2017
Q2 | $1.98M | Buy |
|
|||||
|
2017
Q1 | $1.59M | Buy |
|
|||||
|
2016
Q4 | $1.43M | Buy |
|
|||||
|
2016
Q3 | $1.46M | Buy |
|
|||||
|
2016
Q2 | $1.38M | Sell |
|
|||||
|
2016
Q1 | $1.5M | Sell |
|
|||||
|
2015
Q4 | $1.87M | Sell |
|
|||||
|
2015
Q3 | $1.64M | Sell |
|
|||||
|
2015
Q2 | $1.78M | Sell |
|
|||||
|
2015
Q1 | $1.94M | Sell |
|
|||||
|
2014
Q4 | $1.82M | Sell |
|
|||||
|
2014
Q3 | $1.71M | Hold |
|
|||||
|
2014
Q2 | $1.67M | Sell |
|
|||||
|
2014
Q1 | $1.69M | Buy |
|
|||||
|
2013
Q4 | $1.25M | Buy |
|
|||||
|
2013
Q3 | $1.02M | Buy |
|
|||||
|
2013
Q2 | $883K | Buy |
|